Ethical and legal implications of whole genome and whole exome sequencing in African populations

Simple item page
dc.contributor.authorWright, Galen E.B.
dc.contributor.authorKoornhof, Pieter G.J.
dc.contributor.authorAdeyemo, Adebowale A.
dc.contributor.authorTiffin, Nicki
dc.date.accessioned2016-08-12T10:40:07Z
dc.date.available2016-08-12T10:40:07Z
dc.date.issued2013
dc.description.abstractBACKGROUND: Rapid advances in high throughput genomic technologies and next generation sequencing are making medical genomic research more readily accessible and affordable, including the sequencing of patient and control whole genomes and exomes in order to elucidate genetic factors underlying disease. Over the next five years, the Human Heredity and Health in Africa (H3Africa) Initiative, funded by the Wellcome Trust (United Kingdom) and the National Institutes of Health (United States of America), will contribute greatly towards sequencing of numerous African samples for biomedical research. DISCUSSION: Funding agencies and journals often require submission of genomic data from research participants to databases that allow open or controlled data access for all investigators. Access to such genotype-phenotype and pedigree data, however, needs careful control in order to prevent identification of individuals or families. This is particularly the case in Africa, where many researchers and their patients are inexperienced in the ethical issues accompanying whole genome and exome research; and where an historical unidirectional flow of samples and data out of Africa has created a sense of exploitation and distrust. In the current study, we analysed the implications of the anticipated surge of next generation sequencing data in Africa and the subsequent data sharing concepts on the protection of privacy of research subjects. We performed a retrospective analysis of the informed consent process for the continent and the rest-of-the-world and examined relevant legislation, both current and proposed. We investigated the following issues: (i) informed consent, including guidelines for performing culturally-sensitive next generation sequencing research in Africa and availability of suitable informed consent documents; (ii) data security and subject privacy whilst practicing data sharing; (iii) conveying the implications of such concepts to research participants in resource limited settings. SUMMARY: We conclude that, in order to meet the unique requirements of performing next generation sequencing-related research in African populations, novel approaches to the informed consent process are required. This will help to avoid infringement of privacy of individual subjects as well as to ensure that informed consent adheres to acceptable data protection levels with regard to use and transfer of such information.en_US
dc.identifier.citationWright, G. et al. (2013). Ethical and legal implications of whole genome and whole exome sequencing in African populations. BMC Medical Ethics, 14(21): 2-15en_US
dc.identifier.issn1472-6939
dc.identifier.urihttp://hdl.handle.net/10566/2377
dc.language.isoenen_US
dc.privacy.showsubmitterFALSE
dc.publisherBioMed Central
dc.rights.urihttp://creativecommons.org/licenses/by/4.0
dc.source.urihttp://dx.doi.org/10.1186/1472-6939-14-21
dc.status.ispeerreviewedTRUE
dc.subjectAfrican populationsen_US
dc.subjectEthicalen_US
dc.subjectLegal and societal issuesen_US
dc.subjectNext generation sequencingen_US
dc.subjectWhole genomeen_US
dc.subjectWhole exome sequencingen_US
dc.titleEthical and legal implications of whole genome and whole exome sequencing in African populationsen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Wright_Ethical and legal implications_2013.pdf
Size:
408.37 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Research Articles (Mercantile and Labour Law)